Fundraising FoxEvolutionary Genomics
Castle Rock, US · Nevada corporation · 1 known investors
Find your way into Evolutionary Genomics
Sign up to see every warm intro you have to Evolutionary Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Evolutionary Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Evolutionary Genomics applies genomic analysis and molecular selection detection to advance research in animal science, oncology, and infectious disease therapeutics. The company develops algorithms and research programs for identifying genetic targets and understanding molecular-level evolutionary processes.
Founders & leadership
SB
Steve Bryan WarneckeExecutive
WM
Walter MessierChief Technology Officer and Founder
Board
MB
Mark BoggessBoard director
VO
Virginia OrndorffDirector and Founder
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 4 rounds · 2014–2022
▶$1MraisedMay 2022 · 17 investors · AgricultureRule 506(b)
▶$1MraisedMay 2022 · 17 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Walter MessierExecutive Officer
- Virginia OrndorffDirector
- Mark BoggessDirector
- Steve Bryan WarneckeExecutive Officer, Director
- Amount sold
- $1M
- Minimum investment
- $10K
- First sale
- Mar 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$490KraisedMay 2019 · 4 investors · AgricultureRule 506(b)
▶$490KraisedMay 2019 · 4 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Mark BoggessDirector
- Walter MessierExecutive Officer
- Virginia OrndorffDirector
- Steve Bryan WarneckeExecutive Officer
- Offering amount
- $1.1M
- Amount sold
- $490K
- Minimum investment
- $25K
- First sale
- May 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2.9MraisedMar 2016 · 25 investors · AgricultureRule 506(b)
▶$2.9MraisedMar 2016 · 25 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Mark BoggessDirector
- Steve Bryan WarneckeExecutive Officer, Director
- Walter MessierExecutive Officer
- Virginia OrndorffDirector
- Offering amount
- $3.1M
- Amount sold
- $2.9M
- Minimum investment
- $20K
- First sale
- Feb 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2MraisedMar 2014 · 21 investors · OtherRule 506(b)
▶$2MraisedMar 2014 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Walter MessierExecutive Officer
- Virginia OrndorffDirector
- Steve B WarneckeExecutive Officer, Director
- Mark BoggessDirector
- Offering amount
- $4.5M
- Amount sold
- $2M
- Minimum investment
- $10K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Evolutionary Genomics.
Frequently asked questions
- What does Evolutionary Genomics do?
- Evolutionary Genomics applies genomic analysis and molecular selection detection to advance research in animal science, oncology, and infectious disease therapeutics. The company develops algorithms and research programs for identifying genetic targets and understanding molecular-level evolutionary processes.
- Who are Evolutionary Genomics's investors?
- Evolutionary Genomics's investors include Rockies Venture Club.
- How much funding has Evolutionary Genomics raised?
- Evolutionary Genomics has disclosed $6.4M raised across 4 rounds.
- Where is Evolutionary Genomics headquartered?
- Evolutionary Genomics is headquartered in Castle Rock, US.